Clinical Trials Logo

Clinical Trial Summary

This study aims to evaluate the safety and efficacy of activated and expanded autologous cytokine-killer cells in controlling disease recurrence in colon cancer patients with liver metastasis. 20 patients with confirmed stage IV colon carcinoma with metastasis will be assigned into two groups. Patients in both groups will receive the same therapeutic regimen as usual. Patients in one group additionally will be treated with a single infusion of autologous killer cells that had been previously prepared from peripheral blood.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03329664
Study type Interventional
Source Sabz Biomedicals
Contact Naser Ahmadbeigi, Ph.D
Phone +9821-82415103
Email n-ahmadbeigi@sina.tums.ac.ir
Status Recruiting
Phase Phase 1/Phase 2
Start date February 9, 2020
Completion date January 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04907643 - Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes N/A
Withdrawn NCT05310565 - The Effects of Chiropractic in Adults With Colon Cancer N/A
Not yet recruiting NCT04035096 - The Effectiveness of High-dose Intravenous Vitamin c With Very Low Carbohydrate Diet for Terminal Colon Cancer Patients Phase 1/Phase 2